Company Overview of InnaVirVax SAS
InnaVirVax SAS operates as a biopharmaceutical company. It develops therapeutic vaccines and biotherapy for HIV infection, and prognostic tests for predicting the rate of progression towards AIDS in HIV-infected asymptomatic patients, as well as develops cancer biotherapy products. The company was incorporated in 2008 and is based in Evry, France.
Genopole Entreprises - CAMPUS 1
4 rue Pierre Fontaine
Founded in 2008
33 1 80 85 60 83
33 1 80 85 60 87
Key Executives for InnaVirVax SAS
InnaVirVax SAS Key Developments
Similar Private Companies By Industry
|Norgine Pharma SA||Europe|
Recent Private Companies Transactions
July 11, 2015
To contact InnaVirVax SAS, please visit www.innavirvax.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.